|
Daniel C. Adelman, M.D. joined the company in May 2003 and currently is Senior Vice President of Development and Chief Medical Officer. Prior to joining Sunesis, Dr. Adelman served in various roles, including Vice President of Clinical Operations and Biometrics at Pharmacyclics, Inc. from 1998 to 2003. From 1994 to 1998, he was a Clinical Scientist at Genentech, Inc. Dr. Adelman began his career at the University of California, San Francisco, School of Medicine, where he was Director of Clinical Allergy/Immunology in the Division of Allergy and Immunology, and Director of the Outpatient Center for Clinical Research. He continues to serve as Adjunct Professor of Medicine at the University of California, San Francisco. He holds a B.A. in Biology from University of California, Berkeley and an M.D. from the University of California, Davis. | 